Back to Search
DENISE KALINOWSKI, M.D.
Specialist
NPI: 1033235437Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
MD021613E(PA)
Research & Publications (20)
Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: the methyl pyrazinylketone isonicotinoyl hydrazone series.
PMID 18159922·J Med Chem·2008
8-other
Future of toxicology--iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy.
PMID 17402750·Chem Res Toxicol·2007
8-other
Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analogues.
PMID 17963372·J Med Chem·2007
8-other
Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents.
PMID 17602603·J Med Chem·2007
8-other
Iron chelators of the dipyridylketone thiosemicarbazone class: precomplexation and transmetalation effects on anticancer activity.
PMID 19090766·J Med Chem·2009
8-other
The novel iron chelator, 2-pyridylcarboxaldehyde 2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity.
PMID 19172757·Chem Res Toxicol·2009
7-preclinical
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents.
PMID 18485918·Biochim Biophys Acta·2009
6-review
2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.
PMID 19216562·J Med Chem·2009
8-other
HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents.
PMID 19097949·J Chromatogr B Analyt Technol Biomed Life Sci·2009
4-observational
Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells.
PMID 19140186·Am J Hematol·2009
8-other
Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors.
PMID 19601577·J Med Chem·2009
6-review
Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity.
PMID 18698850·Chem Res Toxicol·2008
8-other
Tuning the antiproliferative activity of biologically active iron chelators: characterization of the coordination chemistry and biological efficacy of 2-acetylpyridine and 2-benzoylpyridine hydrazone ligands.
PMID 17899222·J Biol Inorg Chem·2008
8-other
Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
PMID 18424550·Mol Pharmacol·2008
4-observational
Investigating the antiproliferative activity of quinoline-5,8-diones and styrylquinolinecarboxylic acids on tumor cell lines.
PMID 17904844·Bioorg Med Chem Lett·2007
7-preclinical
Development and validation of HPLC-DAD methods for the analysis of two novel iron chelators with potent anti-cancer activity.
PMID 17166684·J Pharm Biomed Anal·2007
8-other
Investigating biological activity spectrum for novel quinoline analogues.
PMID 17142046·Bioorg Med Chem·2007
8-other
Chelators at the cancer coalface: desferrioxamine to Triapine and beyond.
PMID 17145804·Clin Cancer Res·2006
6-review
PCTH: a novel orally active chelator for the treatment of iron overload disease.
PMID 16540421·Hemoglobin·2006
6-review
Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity.
PMID 17064069·J Med Chem·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3705 5TH AVEUE, CHP MT, SUITE 3950
PITTSBURGH, PA 15213 - Phone
- (412) 641-1635
Quick Facts
- NPI
- 1033235437
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile